Copart, Inc. (CPRT) Stock Analysis
Is CPRT a good investment?
Copart, Inc. (CPRT) has a Plutrex AI rating of 45.0/100 as of October 01, 2026, indicating a Hold consensus. The stock is halal-compliant per AAOIFI standards. Key strength: Profitability fortress with unmatched margins: operating margin 32.0% is +96.8% above the industry average of 16.27%, net margin 31.8% is +200.2% above industry average of 10.59% — reflecting durable network effects, real estate ownership, and near-duopoly moat in salvage auctions that peers cannot replicate quickly. Main concern: Growth deficit is structural and worsening on a relative basis: forward 5-year EPS CAGR 7.66% trails industry 12.49% by 38.7%; trailing earnings -14.6% vs industry +88.07%; revenue +2.4% vs industry +8.10% — all four growth metrics (trailing revenue, trailing earnings, forward 1-year EPS, forward 5-year EPS) show CPRT as the peer group's growth laggard, and the ACV deal has not yet demonstrated any growth inflection.
Investment Summary
CPRT is a world-class business in fundamental deterioration mode, now trading at $27.28 — down 5.5% from the prior report ($28.86) and now below the prior entry zone bottom of $27.50. The stock offers an extraordinary profitability profile (operating margin 32.0% vs industry 16.27%, net margin 31.8% vs industry 10.59%, gross margin 44.1% vs industry 31.35%) paired with a fortress balance sheet (D/E 0.01 vs industry 0.698, $4.49B cash, $1.27B FCF). However, the growth narrative remains deeply troubled: trailing earnings growth of -14.6% YoY, revenue growth of only 2.4%, and a 5-year EPS CAGR of 7.66% that trails the industry average of 12.49% by 38.7%. At P/E 17.59x and PEG 2.30x, valuation has improved modestly (PEG down 15.2% from 2.71) but remains above fair value. The $1.9B ACV Auctions acquisition carries ongoing litigation overhang (Kahn Swick & Foti, Brodsky & Smith investigations) with no resolution. Analyst consensus target of $35.80 implies 31.2% upside from current levels — improved from 24.0% at prior report — but this upside depends on a speculative earnings recovery that lacks current-period evidence. The stock has now fallen below the prior entry zone, warranting a modest downward rating adjustment and zone recalibration.
Key Strengths
- Profitability fortress with unmatched margins: operating margin 32.0% is +96.8% above the industry average of 16.27%, net margin 31.8% is +200.2% above industry average of 10.59% — reflecting durable network effects, real estate ownership, and near-duopoly moat in salvage auctions that peers cannot replicate quickly
- Balance sheet is the strongest in its peer group: D/E 0.01 vs industry 0.698 (98.6% less leverage), $4.49B cash, $1.27B annual FCF — provides full capacity to absorb ACV acquisition cost ($1.9B) including any litigation-forced bid increase, while remaining debt-free and self-funding
- Analyst consensus target of $35.80 implies 31.2% upside from current $27.28 — the largest upside gap in the analysis history of this stock, as price has declined 5.5% from the prior report while the analyst target held perfectly flat at $35.80
Key Concerns
- Growth deficit is structural and worsening on a relative basis: forward 5-year EPS CAGR 7.66% trails industry 12.49% by 38.7%; trailing earnings -14.6% vs industry +88.07%; revenue +2.4% vs industry +8.10% — all four growth metrics (trailing revenue, trailing earnings, forward 1-year EPS, forward 5-year EPS) show CPRT as the peer group's growth laggard, and the ACV deal has not yet demonstrated any growth inflection
- ACV acquisition litigation overhang is unresolved and potentially worsening: two separate law firm investigations now confirmed (Kahn Swick & Foti AND Brodsky & Smith investigating 'potential breaches of fiduciary duty'), creating risk of forced bid increase from $10.50/share on $1.9B deal, deal delay, and continued management distraction — technical momentum has deteriorated further (stock -5.5% since prior report) with no catalyst to reverse the trend
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
CPRT's fundamentals present a sharp quality-growth bifurcation. Profitability is elite: gross margin 44.1% (+12.7pp vs industry 31.35%), operating margin 32.0% (+15.7pp vs industry 16.27%), net margin 31.8% (+21.2pp vs industry 10.59%) — net margin is 3x the industry average, reflecting near-duopoly pricing power in salvage auctions. ROE of 16.2% modestly trails the industry 17.66% average due to $4.49B cash diluting equity; adjusted for excess cash, business ROE is meaningfully higher. Financial health is unmatched: D/E 0.01 vs industry 0.698, $4.49B cash, FCF $1.27B confirming near-100% earnings quality. P/B of 2.78x is reasonable given margin structure. Growth is the critical flaw: revenue +2.4% YoY (vs industry +8.10%), trailing EPS -3.1%, trailing earnings -14.6% (vs industry +88.07%), forward 5-year EPS CAGR 7.66% (vs industry 12.49%). Valuation: P/E 17.59x (improved from 18.61x, now -29.7% below industry 25.01x), PEG 2.30x (improved from 2.71x, now -20.7% below industry 2.89x). Intrinsic value framework (DCF at 7.7% EPS growth, 10% discount rate) implies fair P/E of ~14-16x or $21-$25 intrinsic value. Current $27.28 sits above this range but the gap has narrowed with recent price decline.
News Sentiment
Copart is navigating a complex chapter in its growth story — and investors are watching closely. The company's $1.9 billion bid to acquire ACV Auctions, an online wholesale vehicle marketplace, has become the center of attention, and not all for good reasons. Two separate law firms — Kahn Swick & Foti and Brodsky & Smith — are now investigating whether ACV's board short-changed shareholders by agreeing to Copart's $10.50-per-share offer. Headlines like 'ACV Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price' and 'Brodsky & Smith investigates potential breaches of fiduciary duty' signal legal turbulence that could force Copart to sweeten its offer — meaning that $1.9 billion price tag could climb. The strategic question hanging over the deal — captured perfectly in the headline 'Can Copart's $1.9B ACV Acquisition Deal Drive Long-Term Growth?' — reflects genuine Wall Street skepticism about whether this digital expansion will actually move the needle for a company already struggling with decelerating growth. Meanwhile, analyst sentiment remains divided: one analyst downgraded the stock Thursday while another turned bullish Friday, creating a confusing mixed signal for investors. On the bright side, Copart's international expansion and stronger pricing power are helping cushion weaker domestic insurance volumes. Copart has officially launched the tender offer process, confirming the deal is proceeding — but with litigation clouds forming, the path to closing is anything but clear.
Risk Assessment
PRIMARY RISK: ACV acquisition litigation overhang — two law firms (Kahn Swick & Foti and Brodsky & Smith) now investigating deal adequacy, which could force Copart to raise its $10.50/share bid, increasing deal cost above the announced $1.9B. This directly erodes the cash fortress advantage. SECONDARY RISK: Growth recovery thesis failure — forward 9.1% next-year EPS growth requires reversal from -14.6% trailing, a speculative assumption with no current-period evidence. If ACV integration underperforms or domestic insurance volumes remain soft, the recovery thesis breaks. TERTIARY RISK: Technical breakdown — stock has declined 10.9% from $30.82 (two reports ago) to $27.28, breaking below the prior entry zone of $27.50-$29.50; continued selling pressure could test the $24-$25 intrinsic value floor. MITIGATION: The $4.49B cash position and $1.27B FCF provide a hard floor — even a failed ACV deal and flat earnings trajectory does not threaten solvency. The -29.7% PE discount to peers provides valuation support vs sector-wide repricing. POSITION SIZING: 1.5% maximum — unchanged from prior, as no new information justifies increased risk exposure. Further entry only on confirmed earnings inflection or litigation resolution.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is CPRT a halal stock?
Yes, Copart, Inc. (CPRT) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for CPRT?
Copart, Inc. (CPRT) has a Plutrex AI rating of 45.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is CPRT a good investment?
According to Plutrex AI, CPRT has a Hold rating (45.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in CPRT?
US stocks like CPRT can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in CPRT?
Plutrex AI identifies the main risks for CPRT by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.